NeurAxis Stock
NeurAxis, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Brian Carrico
- Employees
- 24
- Market cap
- $97 M
- IPO
- 09/08/2023
- Web
- neuraxis.com
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets…
NeurAxis stock: price history
1D
-0.5%
1W
+11.1%
1M
+11.0%
6M
+6.6%
YTD
+69.6%
1Y
+145.2%
2Y
+156.7%
5Y
–
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~10% stronger price swings than usual
Ask the agents about NeurAxis
Analyst assessment of NeurAxis
PRICE TARGET LOW
US$8.00
CONSENSUS
US$8.00
MEDIAN
US$8.00
PRICE TARGET HIGH
US$8.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 20/03/2026
NeurAxis stock metrics
P/E
-10
P/B
13.86
EV/EBITDA
-11.82
RETURN ON EQUITY
-33.8%
NET MARGIN
-118.1%
DEBT/EQUITY
0.04
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
68.1%
FLOAT SHARES
8,547,041
AVG. DAILY VOLUME (30D)
175,523
Insider transactions (SEC)
Carrico Brian Allen
Carrico Thomas Joeseph
Henrichs Timothy Robert
Carrico Brian Allen
Carrico Thomas Joeseph
Institutional holders
Comparable stocks
Frequently asked questions about NeurAxis stock
What does NeurAxis do?
NeurAxis, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Brian Carrico, the company employs around 24 people.
The IPO was on 09/08/2023; the stock trades on AMEX under the ticker NRXS.
What do analysts say about NeurAxis stock?
1 analysts rate the stock, the consensus is Buy (as of 20/03/2026).
The average price target is US$8.00, ranging from US$8.00 to US$8.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does NeurAxis report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 10% stronger than usual.
Does NeurAxis pay a dividend?
No, NeurAxis currently does not pay a dividend.
Which stocks are comparable to NeurAxis?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get NeurAxis stock analyzed?
Clicking "Analyze stock" lets five strategies assess NeurAxis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.